David M Weinreich Selected Research

endothelial cell procoagulant activity

9/2004

Alterations in tumor necrosis factor-induced endothelial cell procoagulant activity by hyperthermia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David M Weinreich Research Topics

Disease

12	COVID-19 10/2022 - 01/2021
6	Neoplasms (Cancer) 01/2013 - 04/2002
4	Asthma (Bronchial Asthma) 01/2022 - 10/2021
4	Melanoma (Melanoma, Malignant) 02/2006 - 03/2002
3	Disease Progression 10/2022 - 01/2020
3	Infections 01/2022 - 01/2021
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 02/2006
2	Hypersensitivity (Allergy) 01/2022 - 01/2021
2	Asymptomatic Infections 09/2021 - 01/2021
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 05/2012 - 02/2012
2	Neoplasm Metastasis (Metastasis) 02/2006 - 09/2003
2	Adenocarcinoma 02/2006 - 01/2006
1	Skin Neoplasms (Skin Cancer) 10/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Nasopharyngitis 11/2021
1	Bronchitis 11/2021
1	Headache (Headaches) 11/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2021
1	Lung Diseases (Lung Disease) 11/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 11/2021
1	Macular Edema 09/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 09/2021
1	Pain (Aches) 01/2021
1	Low Back Pain (Lumbago) 01/2021
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2021
1	Atopic Dermatitis (Atopic Eczema) 11/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Rheumatoid Arthritis 01/2020
1	Homozygous Familial Hypercholesterolemia 01/2020
1	Hyperthermia 09/2004

Drug/Important Bio-Agent (IBA)

11	Monoclonal AntibodiesIBA 10/2022 - 01/2020
11	casirivimab and imdevimab drug combinationIBA 10/2022 - 01/2021
4	cemiplimabIBA 10/2022 - 01/2020
4	dupilumabIBA 01/2022 - 11/2020
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2006
3	trebananibIBA 01/2013 - 02/2012
2	LigandsIBA 10/2022 - 01/2021
2	PlatinumIBA 10/2022 - 01/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 11/2020
2	InterleukinsIBA 01/2022 - 09/2003
2	sarilumabIBA 01/2022 - 01/2020
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2022
2	Pharmaceutical PreparationsIBA 12/2021 - 01/2020
2	itepekimabIBA 11/2021 - 10/2021
2	Interleukin-33IBA 11/2021 - 10/2021
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2021 - 02/2006
2	Angiopoietin-1IBA 01/2013 - 02/2012
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2012 - 02/2012
2	CytokinesIBA 02/2006 - 09/2003
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 02/2006 - 09/2003
2	Interleukin-1 (Interleukin 1)IBA 02/2006 - 09/2003
1	COVID-19 VaccinesIBA 10/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Combined Antibody TherapeuticsIBA 01/2022
1	AntibodiesIBA 01/2022
1	Immunoglobulin IsotypesIBA 01/2022
1	AllergensIBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2021
1	GlucocorticoidsIBA 10/2021
1	Interleukin-5 (Interleukin 5)IBA 10/2021
1	Interleukin-4 (Interleukin 4)IBA 10/2021
1	Immunoglobulin E (IgE)IBA 10/2021
1	Antiviral Agents (Antivirals)IBA 09/2021
1	afliberceptIBA 09/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	fasinumabIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	LDL CholesterolIBA 01/2020
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020
1	LipidsIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Adalimumab (Humira)FDA Link 01/2020
1	AngiopoietinsIBA 01/2020
1	evinacumabIBA 01/2020
1	Peptides (Polypeptides)IBA 02/2012
1	TIE-2 Receptor (Receptor, TIE 2)IBA 02/2012
1	Interleukin-8 (Interleukin 8)IBA 02/2006
1	Messenger RNA (mRNA)IBA 02/2006
1	Angiogenic ProteinsIBA 02/2006
1	Biological ProductsIBA 02/2006
1	Recombinant ProteinsIBA 01/2006
1	Thromboplastin (Tissue Factor)IBA 09/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2004
1	endothelial cell procoagulant activityIBA 09/2004
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 09/2003
1	Interleukin-2 (IL2)IBA 03/2002
1	Interferon-alpha (Interferon Alfa)IBA 03/2002

Therapy/Procedure

9	Therapeutics 01/2022 - 04/2002
3	Subcutaneous Injections 12/2021 - 01/2021
2	Drug Therapy (Chemotherapy) 10/2022 - 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Injections 09/2021
1	Intravenous Infusions 01/2020